Cerebral Therapeutics Names Lisa Shafer Chief Scientific Officer

Lisa Shafer has been appointed chief scientific officer of Cerebral Therapeutics, the same position she held at her former company, NeuroBridge Therapeutics. Her experience also includes posts at Teva Pharmaceutical (NYSE: [[ticker:TEVA]]) and Medtronic (NYSE: [[ticker:MDT]]). In other moves, Aurora, CO-based Cerebral named Medtronic veteran Eric Distad its vice president of clinical development. Cerebral is in early-stage studies testing a drug/device combination product that delivers an anti-epileptic drug to the part of the brain responsible for seizures.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan